Mepsgen founded local office in Atlanta, USA in 2019 to expand global business development.
Representing ‘Organ-on-a-chip’ platforms and business as the first global BD center.
Role as an outpost for export of MEPS-X through active partnerships with global pharmaceutical enterprise in the US market.